Quinagolide hydrochloride

This classification denotes an antipsychotic agent with the molecular formula C20H33N3O3S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 33474X943Y, chemically known as sulfamide, n,n-diethyl-n-(1,2,3,4,4a,5,10,10a-octahydro-6-hydroxy-1-propylbenzo(g)quinolin-3-yl)-, monohydrochloride, (3-alpha,4a-alpha,10a-beta)- but more generally known as quinagolide hydrochloride, which bears US NIH Compound Identifier 3086400. European Medicines Agency schedules Quinagolide hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04163MIG. Most nations, for tariff and trade purposes, schedule quinagolide hydrochloride under HS 29339990 and SITC 51577. As of Q4 2014, QUINAGOLIDE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CCCN1C[C@@H](C[C@@H]2[C@@H]1CC3CCCC(C3C2)O)NS(=O)(=O)N(CC)CC.CL.